IMF Opens March ‘Resilience’ Campaign for Myeloma Action Month
With an emphasis on the ability of patients and…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Video: Bionews’ Social Media Campaign Highlights #WhatMakesMeRare
In recognition of Rare Disease Day Feb. 29,…
FDA Approves Sarclisa Combo to Treat Advanced Multiple Myeloma
The U.S. Food and Drug Administration (FDA) has…
Causes of Myeloma
Myeloma is a form of blood cancer that…
Loss of Specific Gene May Help Drive Myeloma Progression, Study Finds
One of the most common genomic defects in multiple…
CLR 131 Helps Heavily Treated Multiple Myeloma Patients, Phase 2 Data Show
Cellectar Biosciences’ lead candidate CLR 131 safely…
